HEALTH OF WOMAN.2015.1(97):45-48 
 

Clinical application of Ksilаt in complex therapy of severe early toxicosis pregnant 
 

Davydova J. V., Limanskaja A. U., Today C. N., Mokrik A. N.

SІ Іnstitute of pediatrics, obstetrics and gynecology of NAMS of Ukraine 
 

Recently, the evaluation of the role of early toxicosis in the implementation pregnancy has undergone significant changes. Early morning sickness is severe stage not only significantly impairs quality of life, but can lead to serious status of women and the loss of the pregnancy. Isotonic solution Ksilat (producer – firm «Yuria-Pharm») is an effective means of correction dysmetabolic disorders (acidosis) in pregnant women with severe early toxicity. The inclusion of Ksilit in the complex treatment of pregnant women with uncontrollable vomiting as a manifestation of early toxicosis improves the adaptation of the food channel for the upcoming enteral nutritional load. 
 

Key words: pregnancy, early toxicosis, sickness, acidosis, treatment, Ksilat. 
 

REFERENCES

1. American College of Obstetrics and Gynecology, authors. ACOG (American College of Obstetrics and Gynecology) Practice Bulletin: nausea and vomiting of pregnancy. Obstet Gynecol. 2004;103:803–814.

2. Eliakim R., Abulafia O., Sherer D.M. 2000. Hyperemesis gravidarum: a current review. Am J Perinatol. 17:207–218. http://dx.doi.org/10.1055/s-2000-9424; PMid:11041443

3. El Mallakh, R.S., Liebowitz N.R., Hale M.S. 2009. Hyperemesis gravidarum as conversion disorder. J. Nerv. Ment. Dis. 178:655–659. http://dx.doi.org/10.1097/00005053-199010000-00007

4. El. Younis, C.M., Abulafia O., Sh’erer D.M. 2008. Rapid marked’ response of severe hyperemesis gravidarum to oral erythromycin. Am. J. Perinatol. 15:533–534. http://dx.doi.org/10.1055/s-2007-994055; PMid:9890250

5. Erdem A., Arslan M., Erdem M. 2002. Detection of Helicobacter pylori seropositivity in < hyperemesis gravidarum and correlation with symptoms. Am. J. Perinatol. 19:87–92. http://dx.doi.org/10.1055/s-2002-23559; PMid:11938482

6. FDA Approved obstetrics drugs: their effects on mother and baby. Doris Haire. FDA, 2001.

7. FitzGerald C.M. 2004. Nausea and vomiting in pregnancy. Br. J. Med. Psychol. 57:159–165.

8. Flaxman S.M., Sherman P.W. 2000. Morning sickness: a mechanism for protecting mother and embryo. Rev. Biol. 75:113–148. http://dx.doi.org/10.1086/393377

9. Frankel E.N. 2005. Chemistry of free radical and singlet oxidation of lipids. Prog. Lipid. Res. 23:197.

10. Frigo P., Lang C., Reisenberger K. 2008. Hyperemesis gravidarum associated with Helicobacter pylori seropositivity. Obstet. Gynecol. 91:615–617. http://dx.doi.org/10.1016/S0029-7844(97)00709-6

11. Fukada Y., Ohta S., Mizuno K. 2009. Rhabdomyolysis secondary to hyperemesis gravidarum. Acta Obstet. Gynecol. Scand. 78:71.

12. Furneaux E.C., Langley-Evans A.J., Langley-Evans S.C. 2001. Nausea and vomiting’of pregnancy: endocrine basis and contribution to pregnancy outcome. Obstet. Gynecol. Surv. 56:775–782. http://dx.doi.org/10.1097/00006254-200112000-00004; PMid:11753180

13. Gadsby R., Barnie-Adshead A.M., Jagger C. 2003. A prospective study of nausea and vomiting during pregnancy. Br. J. Gen. Pract. 43:245–248.

14. Gerhard I. 2008. Endocrinology of normal and disordered early pregnancy. Gynдkologe 21;3:201–202.

15. Ghani R. 2003. The use of total parenteral nutrition in protracted hyperemesis gravidarum J. Obstet. Gynaecol. 23:199–201.

16. Jueckstock J.K., Kaestner R., Mylonas I. 2010. Managing hyperemesis gravidarum: a multimodal challenge. BMC Med. 8:46.

17. Knobloch V., Miler І. 2002. The development of immune logical relationship between mother and fetus-under physiological and pathological conditions. Allerg. Immunol. Bd. 34;4:219–231.

18. Koch K.L., Stern R.M., Vascy M. 2010. Gastric dysrhythmias and nausea of pregnancy. Dig. Dis. Sci. 35:961–968. http://dx.doi.org/10.1007/BF01537244

19. Kocak I., Akcan Y., Ustun C. 2009. Helicobacter pylon seropositivity in patients with hyperemesis gravidarum. Int. J. Gynaecol. Obstet. 66:251–254. http://dx.doi.org/10.1016/S0020-7292(99)00091-0

20. Kuscu N.K., Koyuncu F. 2002. Hyperemesis gravidarum: current concepts and management. Postgrad Med J. 78:76–79. http://dx.doi.org/10.1136/pmj.78.916.76; PMCid:PMC1742282

21. Levine M.G., Esser D. 1988. Total parental nutrition for the treatment of severe hyperemesis gravidarum: maternal nutritional effects and fetal outcome. Obstet Gynecol. 72:102–107.

22. Nelson-Piercy C. 1998. Treatment of nausea and vomiting in pregnancy: when should it be treated and what can be safely taken? Drug Saf. 19:155–164. http://dx.doi.org/10.2165/00002018-199819020-00006

23. Nelson-Piercy C., Fayers P., de Swiet M. 2001. Randomised, double-blind, placebo-controlled trial of corticosteroids for the treatment of hyperemesis gravidarum. BJOG. 108:9–15. http://dx.doi.org/10.1111/j.1471-0528.2001.00017.x; http://dx.doi.org/10.1016/S0306-5456(00)00017-6

24. Sonkusare S. 2008. Hyperemesis gravidarum: a review. Med Journal Malaysia 63:272–276.

25. Tan P.C., Jacob R., Quek K.F., Omar S.Z. 2007. Pregnancy outcome in hyperemesis gravidarum and the effect of laboratory clinical indicators of hyperemesis severity. J Obstet Gynaecol Res. 33:457–464. http://dx.doi.org/10.1111/j.1447-0756.2007.00552.x; PMid:17688612

26. Tan P.C., Khine P.P, Vallikkannu N., Zawiah S.Z. 2010. Promethazine compared with metoclopramide for hyperemesis gravidarum: a randomized controlled trial. Obstet Gynecol. 115:975–981. http://dx.doi.org/10.1097/AOG.0b013e3181d99290; PMid:20410771

27. Taylor R. Successful management of hyperemesis gravidarum using steroid therapy. 1996. QJM. 89:103–107. http://dx.doi.org/10.1016/S0020-7292(96)02778-6

28. Tsang I.S., Katz V.L., Wells S.D. 1996. Maternal and fetal outcomes in hyperemesis gravidarum. Int J Gynaecol Obstet. 55:231–235.

29. Veenendaal M.V., van Abeelen A.F., Painter R.C., et al. 2011. Consequences of hyperemesis gravidarum for offspring: a systematic review and meta-analysis. BJOG 118:1302–1313. http://dx.doi.org/10.1111/j.1471-0528.2011.03023.x; PMid:21749625